Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Mutations in the spike protein affect drug binding and effectiveness.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Hair loss doesn't affect COVID-19 severity.

Low testosterone may increase COVID-19 severity in men.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Microscopes are essential for telling apart human and animal hair in criminal investigations.

The scalp microbiome may be a key factor in treating hair loss.

Balancing testosterone may reduce COVID-19 severity.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

Early diagnosis and a combination of treatments can effectively manage hair loss and improve quality of life.

Hair health is affected by various conditions and requires personalized treatment.